|
|||||
|
|
A phase I trial of oral metronomic vinorelbine plus capecitabine in patients with metastatic breast cancer |
|
| Authors: | Zacharenia Saridaki Nikolaos Malamos Panagiotis Kourakos Aristides Polyzos Alexandros Ardavanis Nikolaos Androulakis Kostas Kalbakis Lambros Vamvakas Vassilis Georgoulias Dimitris Mavroudis |
| Affiliation: | (1) Hellenic Oncology Research Group (HORG), 55 Lomvardou str, 11470 Athens, Greece |
| Abstract: | PurposeTo determine the dose-limiting toxicities (DLTs) and the maximum tolerated doses (MTD) of oral metronomic vinorelbine with capecitabine in patients with metastatic breast cancer (MBC). |
| Keywords: | |
| 本文献已被 PubMed SpringerLink 等数据库收录！ | |